Seebri Breezhaler, 50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation

7680625800020 CH-62580 Mikrogramm

Associated product:

SEEBRI breezhaler caps inh 50 mcg 3 x 30 pce
Seebri Breezhaler, 50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation
Seebri Breezhaler, 50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation
Seebri Breezhaler, 50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Kapsel(n)
Galenic form
Mikrogramm
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/12/2022
Patient information leaflet
Français
23/12/2022
Patient information leaflet
Italien
23/12/2022
Summary of Product Characteristics
Allemand
27/01/2021
Summary of Product Characteristics
Français
27/01/2021
Summary of Product Characteristics
Italien
27/01/2021

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
44.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 131.85
Specialties list
Yes
Generic
No
SL addition date: 01/09/2013

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
62580
Drug name
Seebri Breezhaler, 50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation
Galenic form
KAHI
ATC Code
R03BB06
Authorization status
Z
Dispensing category
B
First authorization
29/04/2013
Authorization expiration date
31/12/9999
IT Number
03.04.3.
Domain
Human medicine
Field of application
COPD

Package details

Description (FR)
SEEBRI breezhaler caps inh 50 mcg 3 x 30 pce
Description (DE)
SEEBRI Breezhaler Inh Kaps 50 mcg 3 x 30 Stk
Market launch
29/04/2013
Narcotic (BTM)
No

Other package sizes (1)

SEEBRI breezhaler caps inh 50 mcg 30 pce
30 KAP
GTIN: 7680625800013
View